top of page

New Pharmaceuticals in the Environment Cross-Government Group

Details of the new Pharmaceuticals in the Environment (PiE) cross-government group working to reduce the impacts of pharmaceuticals in the environment

The recently formed Pharmaceuticals in the Environment (PiE) Group is a UK cross-government platform to enable discussion and knowledge exchange relating to pharmaceuticals in the environment from human, veterinary, and, where there is cross-over, agricultural and non-agricultural sources.

We anticipate that membership will grow to include more organisations from across the UK government and devolved administrations. Currently, membership includes:

  • Veterinary Medicines Directorate (VMD)

  • Environment Agency (EA)

  • Health and Safety Executive (HSE)

  • Veterinary Products Committee (VPC)

  • Department for Environment, Food and Rural Affairs (Defra)

  • Medicines & Healthcare products Regulatory Agency (MHRA)

At our first meeting, held in April 2023, we agreed our purpose – to develop a co-ordinated strategy to reduce the impacts of pharmaceuticals on the environment (biodiversity) and human health.

We also identified our first priority area, which is to gain a better understanding of the potential sources of fipronil and imidacloprid levels detected in UK surface waters and to work towards reducing these levels.

bottom of page